 Pfenex Inc. NYSE American: PFNX today announced that its commercialization partner, Alvogen, has launched Teriparatide Injection in the United States. Teriparatide Injection also referred to as PF708 and BonsityTM is a prescription medicine approved for several uses, including in postmenopausal women with osteoporosis who are at high risk for having bone fractures. 